PETER FENN: Open Payments
NPI 1831140268 · BUIES CREEK, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,012 in 50 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,068 · 2025 $1,012
Food & beverage: $1,012
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 13 | $220 |
| AstraZeneca Pharmaceuticals LP | 8 | $201 |
| Lilly USA, LLC | 8 | $121 |
| Corcept Therapeutics | 4 | $116 |
| ABBVIE INC. | 5 | $116 |
| PFIZER INC. | 3 | $60 |
| Exact Sciences Corporation | 2 | $45 |
| Novo Nordisk Inc | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Hologic Sales and Service, LLC | 1 | $24 |
Products named: TRELEGY ELLIPTA, Korlym, VRAYLAR, BREZTRI, AIRSUPRA, JARDIANCE, MOUNJARO, ELIQUIS.
Industry payments across NC — which companies pay providers there.
